Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)

被引:0
|
作者
Jamie D. Croxtall
Sohita Dhillon
机构
[1] Adis,
来源
Drugs | 2012年 / 72卷
关键词
Conjugate Vaccine; Meningococcal Disease; Invasive Meningococcal Disease; Geometric Mean Titre; Meningococcal Vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
Nimenrix™ (MenACWY-TT) is a quadrivalent meningococcal conjugate vaccine, comprising the polysaccharide serogroups A, C, W135 and Y, and tetanus toxoid (TT) as carrier protein. It is the first quadrivalent vaccine (administered as a single dose) to be approved in Europe for active immunization of individuals aged ≥12 months against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W135 and Y.
引用
收藏
页码:2407 / 2430
页数:23
相关论文
共 50 条